openPR Logo
Press release

Future of Cancer Pain Market: Multimodal Approaches and Personalized Medicine at the Core | Top Companies are Mundipharma International., Orexo AB, DAIICHI SANKYO COMPANY.

06-23-2025 03:19 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Cancer Pain Market

Cancer Pain Market

The Global Cancer Pain Market reached US$ 7.15 billion in 2023 and is expected to reach US$ 11.02 billion by 2031, growing at a CAGR of 5.6% during the forecast period 2024-2031.

The Cancer Pain Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/cancer-pain-market?rk

The Cancer Pain Market refers to the global industry focused on the development, production, and commercialization of various therapies and devices aimed at managing pain associated with cancer and its treatments. Cancer pain can arise from tumor progression, nerve compression, treatment side effects, or surgical interventions. The market encompasses pharmaceuticals (such as opioids, NSAIDs, anticonvulsants, antidepressants), targeted drug delivery systems, implantable pain pumps, non-pharmacological therapies, and digital health interventions aimed at improving patient quality of life.

Emergence of Non-Opioid Alternatives
Due to concerns over opioid dependency and regulatory scrutiny, pharmaceutical companies are increasing investments in non-opioid drugs like cannab*noid-based therapies and nerve growth factor (NGF) inhibitors.

Rise of Digital Therapeutics
New digital apps and AI-driven platforms are being introduced to help monitor cancer pain and adjust treatment plans in real time, offering personalized pain management solutions.

FDA Approvals for Extended-Release Formulations
Recent approvals for novel extended-release opioid formulations aim to provide longer-lasting pain relief with lower risks of misuse.

Cancer Pain Market: Industry Giants and Emerging Leaders:

CK Life Sciences (WEX Pharmaceuticals Inc), Mundipharma International., Orexo AB, DAIICHI SANKYO COMPANY, LIMITED., Hisamitsu Pharmaceutical Co., Inc., Pfizer Inc., Grünenthal, Galena Biopharma and Meda Pharmaceuticals.

Cancer Pain Industry News:

On February 13, 2024, Radformation, a main supplier of radiation oncology software solutions, declared its strategic partnership with Icon Group. This collaboration unites the aptitude of the two organizations to change disease care through imaginative work processes and high-level software solutions.

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-pain-market

Segment Covered in the Cancer Pain Market:

By Drug Class: Opioids, NSAIDs, Morphine, Non-Opioids, Nerve Blockers, Others.

By Application: Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Others.

By Route of Administration: Oral, Parenteral, Others.

By End-Users: Hospitals, Homecare, Specialty Clinics, Others.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Cancer Pain Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Cancer Pain market?

➠ Who are the global key manufacturers of the Cancer Pain Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Cancer Pain market opportunities and threats faced by the vendors in the global Cancer Pain Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Cancer Pain market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=cancer-pain-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Cancer Pain Market: Multimodal Approaches and Personalized Medicine at the Core | Top Companies are Mundipharma International., Orexo AB, DAIICHI SANKYO COMPANY. here

News-ID: 4078312 • Views:

More Releases from DataM Intelligence 4market Research LLP

Frozen Fruits Market Surges Toward US$6.54 Billion by 2030 - Asia-Pacific Leads with 43% Share as Organic, Plant-Based & IQF Trends Redefine Global Nutrition
Frozen Fruits Market Surges Toward US$6.54 Billion by 2030 - Asia-Pacific Leads …
According to DataM Intelligence, the global frozen fruits market size was valued at US$3,957.4 million in 2022 and is forecasted to reach US$6,549.4 million by 2030, growing at a CAGR of 6.5% from 2024 to 2031. This steady growth is propelled by rising health consciousness among consumers, increasing demand for convenient and nutritious food options, expanding food processing and service sectors, growing preference for organic and plant-based products, surging popularity
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates 35% Share Amid Rising FDA Compliance & Livestock Safety Demands
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates …
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus on
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Customizable Desserts & Bakery Personalization Fuel North America's 38% Revenue Dominance
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo …
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, and
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and Construction Sectors | Top Companies are Arconic Corporation, Bahrain Aluminum Extrusion Co. (BALEXCO), Century Extrusions Ltd
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and …
Global Aluminum Extrusion Market reached US$ 78.7 billion in 2022 and is expected to reach US$ 117.8 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2025-2031. According to DataM Intelligence has published a new research report on "Aluminium Extrusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For